Recurrent strokes - Manifestation of the POEMS syndrome?;Rezidivierende zerebrovaskulare Insulte - Manifestation des POEMS- Syndroms?

Schweizerische Medizinische Wochenschrift

Volumn 128, Issue 26, 1998, Pages 1059-1064

  Forster, A ^a   Muri R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; FOOT DISEASE; HEART INFARCTION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PARAPROTEINEMIA; RECURRENT DISEASE; STROKE; CEREBROVASCULAR DISEASE; MIDDLE AGED; RISK FACTOR;

CEREBROVASCULAR DISORDERS; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POEMS SYNDROME; RECURRENCE; RISK FACTORS;

EID: 0032572206     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bardwick PA, Zvaifler NJ, Gill GN, Newmann D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980;59:311-22.
2. Nakanashi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984;34:712-20.
3. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med 1992;327:1919-23.
4. Soubrier MJ, Dubost JJ, Sauvezie BJM, and the French Study Group on POEMS syndrome. A study of 25 cases and a review of the literature. Am J Med 1994;97:543-53.
5. Gherardi RK, Bélec L, Soubrier M, Malapert D, Zuber M, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 1996;87:1458-65.
6. Lesprit P, Romain FJ, Gherardi R, Bélec L, Paris D, et al. Acute arterial obliteration: a new feature of the POEMS syndrome? Medicine 1996;75:226-32.
7. Gherardi R, Baudrimont M, Kujas M, Malapert D, Lange F, et al. Pathological findings in three non-Japanese patients with the POEMS syndrome. Virchows Arch A Pathol Anat 1988;413:357-65.
8. Saida K, Kawakami H, Ohta M, Iwamura K. Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle Nerve 1997;20:486-92.
9. Vital C, Gherardi R, Vital A, Kopp N, Pellissier JF, et al. Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathol 1994;87:302-7.
10. Sobue G, Doyu M, Watanabe M, Hayashi F, Mitsuma T. Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case. Acta Neuropathol 1992;84:171-7.
11. Stewart PM, McIntyre MA, Edwards CRW. The endocrinopathy of POEMS syndrome. Scot Med J 1989;34:520-2.
12. Gimenez-Roqueplo AP, Casanova S, Bruckert E, Bolgert F, Turpin G. Les endocrinopathies dans le POEMS syndrome. A propos de quatre observations. Presse Méd 1994;23: 1243-6.
13. Frizzera G. Castleman's disease and related disorders. Sem Diagn Pathol 1988;5:346-64.
14. Shahidi H, Myers JL, Kvale PA. Castleman's disease. Mayo Clin Proc 1995;70:969-77.
15. Shelly WB, Shelly ED. The skin changes in the Crow-Fukase (POEMS) syndrome. A case report. Arch Dermatol 1987; 123:85-7.
16. Dereure O, Guillot B, Dandurand M, Bataille R, Chertok P, et al. Les signes cutanés du syndrome POEMS. A propos de 3 observations et revue de la littérature. Ann Dermatol Venereol 1990;117:283-90.
17. Mizuiri S, Mitsuo K, Sakai K, Hayashi I, Suzuki T, et al. Renal involvement in POEMS syndrome. Nephron 1991;59: 153-6.
18. Virmani R, Popovsky MA, Roberts WC. Thrombocytosis, coronary thrombosis and acute myocardial infarction. Am J Med 1979;67;498-506.
19. Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P, Lotz M. Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer 1992;69:2697-703.
20. Gherardi RK, Bélec L, Fromont G, Malapert D, Gaulard P, Degos JD. Elevated levels of interleukin-1b (IL-1b) and IL-6 in serum and increased production of IL-1b mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome. Blood 1994;83:2587-93.
21. Gherardi RK, Authier FJ, Bélec L. Les cytokines pro-inflammatoires: Une clé pathogénetique du syndrome POEMS. Rev Neurol (Paris) 1996;152:409-12.
22. Saida K, Ohta M, Kawakami H, Saida T. Cytokines and myelin antibodies in Crow-Fukase syndrome. Muscle Nerve 1996;19:1620-2.
23. Gherardi RK, Chouaib S, Malapert D, Bélec L, Intrator L, Degos JL. Early weight loss and high serum tumor necrosis factor-α levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome. Ann Neurol 1994; 35:501-5.
24. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996;347:702.
25. Soubrier M, Dubost JJ, Serre AF, Ristori JM, Sauvezie B, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997;40:786-7.
26. Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I. Long-term melphalan-prednisone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry 1997;63:385-7.
27. Delauche-Cavallier MC, Lcauvel JP, Danon F, Peraldi MN, Divine M, Seligmann M. Neuropathie périphérique et proliférations plasmocytaires. A propos de 17 observations. Ann Méd Interne 1990;141:651-6.
28. Rushton DI. Peripheral sensorimotor neuropathy associated with a localized myeloma. Br Med J 1965;2:203-5.
29. Amiel JL, Machover D, Droz JP. Dyscrasie plasmocytaire avec artériopathie, polyneuropathie, syndrome endocrinien. Ann Méd Interne 1975;126:745-9.
30. Solomons REB, Gibbs DD. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes: the POEMS syndrome. J R Soc Med 1982;75:553-5.
31. Tobin MJ, Fitzgerald MX. The Japanese plasma cell dyscrasia syndrome: case report and theory of pathogenesis. Postgrad Med J 1982;58:786-9.
32. Semble EL, Challa VR, Holt CA, Pisko EJ. Light and electron microscopic findings in POEMS, or Japanese multi-system syndrome. Arthritis Rheum 1986;29:286-91.
33. Jackson A, Burton IE. Premature vascular calcification in a case of POEMS syndrome. Eur J Radiol 1991,13:203-6.
34. Zenone T, Bastion Y, Salles G, Rieux C, Morel D, et al. POEMS syndrome, arterial thrombosis and thrombocythaemia. J Intern Med 1996;240:107-9.
35. Kato T, Kaneko E, Numano F, Oniki T, Hashimoto Y, et al. Vasospastic angina in Crow-Fukase syndrome. Am Heart J 1992;124:505-7.
36. Yamada M, Yamawaki M, Michikawa M, Kameda N, Furukawa T, Kaneko E. The Crow-Fukase (POEMS) syndrome with vasospastic angina. Eur Neurol 1994;34:110.
37. Mochizuki T, Sawada S. Crow-Fukase syndrome: a case associated with vasospastic angina. Acta Neurol (Napoli) 1994;16:170-6.
38. Scully RE, Mark EJ, McNeely WF, McNeely BU. Case records of the Massachusetts General Hospital. Case 10 1987. N Engl J Med 1987;316:606-18.
39. Manning WJ, Goldberger AL, Drews RE, Drews RE, Goldstein BJ, et al. POEMS syndrome with myocardial infarction: observations concerning pathogenesis and review of the literature. Sem Arthritis Rheum 1992;22:151-61.
40. Huth M, Gordon D, Verrier ED, Otto CM. Aortic valvular fibroma as a source of systemic emboli in POEMS syndrome. J Am Soc Echocardiogr 1991;4:401-4.